Patent details

EP3736261 Title: COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

Basic Information

Publication number:
EP3736261
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP201800067
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
French Title of Invention:
COMPOSÉS ET COMPOSITIONS POUR L'ADMINISTRATION INTRACELLULAIRE D'AGENTS THÉRAPEUTIQUES
German Title of Invention:
VERBINDUNGEN UND ZUSAMMENSETZUNGEN ZUR INTRAZELLULÄREN VERABREICHUNG VON THERAPEUTISCHEN WIRKSTOFFEN
SPC Number:

Dates

Filing date:
16/09/2016
Grant date:
11/10/2023
EP Publication Date:
11/11/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/10/2023
EP B1 Publication Date:
11/10/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/09/2024
Expiration date:
16/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/06/2024
 
 

Name:
ModernaTX, Inc.
Address:
325 Binney Street, Cambridge, MA 02142, United States (US)

History of Owners

From:
14/06/2024
To:
14/06/2024

Name:
ModernaTX, Inc.
Address:
325 Binney Street, Cambridge, MA 02142, United States (US)

From:
04/10/2023
To:
14/06/2024

Name:
ModernaTX, Inc.
Address:
200 Technology Square, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
CORNEBISE, Mark
Address:
United States (US)

2

Name:
KUMARASINGHE, Ellalahewage Sathyajith
Address:
United States (US)

3

Name:
BENENATO, Kerry E.
Address:
United States (US)

Priority

1

Priority Number:
201562220085 P
Priority Date:
17/09/2015
Priority Country:
United States (US)

2

Priority Number:
201562220091 P
Priority Date:
17/09/2015
Priority Country:
United States (US)

3

Priority Number:
201562252316 P
Priority Date:
06/11/2015
Priority Country:
United States (US)

4

Priority Number:
201562253433 P
Priority Date:
10/11/2015
Priority Country:
United States (US)

5

Priority Number:
201562266460 P
Priority Date:
11/12/2015
Priority Country:
United States (US)

6

Priority Number:
201662333557 P
Priority Date:
09/05/2016
Priority Country:
United States (US)

7

Priority Number:
201662382740 P
Priority Date:
01/09/2016
Priority Country:
United States (US)

8

Priority Number:
201662393940 P
Priority Date:
13/09/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07C 271/20; C07C 279/12; C07C 279/28; C07C 279/32; C07D 249/04; C07D 263/20; C07D 265/33; C07D 271/06; C07D 271/10; C07D 279/28; A61K 38/17; A61K 38/18; A61P 3/00; A61P 9/00; A61P 31/00; A61P 35/00; A61P 43/00; A61P 37/00;

Publication

European Patent Bulletin

1

Issue number:
202341
Publication date:
11/10/2023
Description:
Grant (B1)

2

Issue number:
202346
Publication date:
15/11/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202429
Publication date:
17/07/2024
Description:
Change of owner's name or address

4

Issue number:
202429
Publication date:
17/07/2024
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages